Long-term Follow-up of Living Liver Donors: A Single-center Experience
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 476
- 主要终点
- health-related quality of life (HRQoL)
研究概览
简要总结
Data on the long-term consequences of living liver donation are scarce. This study examined clinical, laboratory, and radiological parameters and long-term health-related quality of life (HRQoL) in 237 living liver donors and 239 matched controls during 48 to 168 months of postdonation follow-up.
详细描述
Data on the long-term consequences of living liver donation are scarce. This study examined clinical, laboratory, and radiological parameters and long-term health-related quality of life (HRQoL) in 237 living liver donors and 239 matched controls during 48 to 168 months of postdonation follow-up.
We used the 36-item short-form health survey (short form-36 health survey, version 1 [SF-36]). The scores for the 4 following subscales were higher in nondonors than in donors: physical functioning (P = 0.009), role limitations due to physical health (P = 0.002), energy/fatigue (P < 0.001), and bodily pain (P < 0.001). The scores on the 8 subscales of the SF-36 were higher in donors with living recipients than in donors whose recipients died (P < 0.001). Our results suggest that living donor right hepatectomy is safe and results in a postdonation HRQoL similar to that of nondonors in those donors whose recipients are healthy, while donors whose recipients die have a lower HRQoL that is significantly negatively correlated with the time since recipient death and improves over time.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 50 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •age 18-50 years
- •no comorbidities.
- •BMI less than 30 kg/m
- •compatible ABO group.
排除标准
- •Older than 50 years.
- •Associated comorbidities.
- •Noncompatible ABO group.
结局指标
主要结局
health-related quality of life (HRQoL)
时间窗: 4 to 16 years of follow up
health-related quality of life (HRQoL) (36-item short-form health survey, version 1 \[SF-36\]).
次要结局
未报告次要终点
研究者
Ahmed Shehta
MD, PhD
Mansoura University
